224 related articles for article (PubMed ID: 28424554)
1. Arterial stiffness in hematologic malignancies.
Mozos I; Borzak G; Caraba A; Mihaescu R
Onco Targets Ther; 2017; 10():1381-1388. PubMed ID: 28424554
[TBL] [Abstract][Full Text] [Related]
2. Aortic wall stiffness as a side-effect of anti-cancer medication.
Solomou E; Aznaouridis K; Masoura C; Cutajar I; Toutouzas K; Vlachopoulos C; Tousoulis D
Expert Rev Cardiovasc Ther; 2019 Nov; 17(11):791-799. PubMed ID: 31715108
[No Abstract] [Full Text] [Related]
3. Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases.
Mozos I; Malainer C; Horbańczuk J; Gug C; Stoian D; Luca CT; Atanasov AG
Front Immunol; 2017; 8():1058. PubMed ID: 28912780
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between Oxidative and Nitrosative Stress and Arterial Stiffness.
Mozos I; Luca CT
Curr Vasc Pharmacol; 2017; 15(5):446-456. PubMed ID: 28155616
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenesis in patients with hematologic malignancies].
Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
[TBL] [Abstract][Full Text] [Related]
6. The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Freireich EJ; Keating M; Cabanillas F; Barlogie B
Cancer; 1984 Dec; 54(11 Suppl):2741-50. PubMed ID: 6208991
[TBL] [Abstract][Full Text] [Related]
7. Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.
Sethi TK; Basdag B; Bhatia N; Moslehi J; Reddy NM
Curr Hematol Malig Rep; 2017 Jun; 12(3):257-267. PubMed ID: 28233150
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Artery Disease and Stroke.
Zito C; Manganaro R; Carerj S; Antonini-Canterin F; Benedetto F
J Cardiovasc Echogr; 2020 Apr; 30(Suppl 1):S17-S25. PubMed ID: 32566462
[TBL] [Abstract][Full Text] [Related]
9. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
Falanga A; Rickles FR
Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
[TBL] [Abstract][Full Text] [Related]
10. Hypertension in hematologic malignancies and hematopoietic cell transplantation: An emerging issue with the introduction of novel treatments.
Gavriilaki E; Gkaliagkousi E; Grigoriadis S; Anyfanti P; Douma S; Anagnostopoulos A
Blood Rev; 2019 May; 35():51-58. PubMed ID: 30898309
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Omega 3 Fatty Acids in Atherosclerosis and Arterial Stiffness: An Overview of their Actions.
Verveniotis A; Siasos G; Oikonomou E; Tsigkou V; Papageorgiou N; Zaromitidou M; Psaltopoulou T; Marinos G; Deftereos S; Vavuranakis M; Stefanadis C; Papavassiliou AG; Tousoulis D
Curr Pharm Des; 2018; 24(17):1865-1872. PubMed ID: 29564974
[TBL] [Abstract][Full Text] [Related]
12. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
[TBL] [Abstract][Full Text] [Related]
13. [Advances in the target therapy of hematological malignancies].
Niu T; Liu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):642-6. PubMed ID: 25286692
[TBL] [Abstract][Full Text] [Related]
14. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
Woodman RJ; Chew GT; Watts GF
Drugs; 2005; 65(1):31-74. PubMed ID: 15610050
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of endothelial function and arterial stiffness in HIV-infected patients: a pilot study.
Balsam P; Mikuła T; Peller M; Suchacz M; Puchalski B; Kołtowski Ł; Główczyńska R; Wiercińska-Drapalo A; Opolski G; Filipiak KJ
Kardiol Pol; 2015; 73(5):344-51. PubMed ID: 25428814
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of angiogenesis inhibitors in hematologic malignancies.
Giles FJ
Oncology (Williston Park); 2002 May; 16(5 Suppl 4):23-9. PubMed ID: 12102577
[TBL] [Abstract][Full Text] [Related]
18. Raiders of the lost mark - endothelial cells and their role in transplantation for hematologic malignancies.
Blix ES; Husebekk A
Leuk Lymphoma; 2016 Dec; 57(12):2752-2762. PubMed ID: 27396981
[TBL] [Abstract][Full Text] [Related]
19. Arterial Stiffness Assessed by Cardio-Ankle Vascular Index.
Namba T; Masaki N; Takase B; Adachi T
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357449
[TBL] [Abstract][Full Text] [Related]
20. Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study.
Souza CA; Simões R; Borges KBG; Oliveira AN; Zogeib JB; Alves B; Malachias MVB; Drummond-Lage AP; Rezende BA
Arq Bras Cardiol; 2018 Nov; 111(5):721-728. PubMed ID: 30281690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
